(Q38264485)

1 September 2017

1 reference

title

Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair (English)

1 reference

1 September 2017

0 references

1 reference

1 reference

1

Vivekanantham S

1 reference

1 September 2017

2

Shah S

1 reference

1 September 2017

3

Dewji R

1 reference

1 September 2017

4

Dewji A

1 reference

1 September 2017

5

Khatri C

1 reference

1 September 2017

6

Ologunde R

1 reference

1 September 2017

language of work or name

English

0 references

publication date

3 November 2014

1 reference

International Journal of Neuroscience

1 September 2017

published in

1 reference

1 September 2017

volume

125

1 reference

1 September 2017

issue

10

1 reference

1 September 2017

page(s)

717-725

1 reference

Glial reactions in Parkinson's disease

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Molecular pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Rate of cell death in parkinsonism indicates active neuropathological process

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Regulating factors for microglial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

CNS infiltration of peripheral immune cells: D-Day for neurodegenerative disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Inflammation and neurodegeneration in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Oxidative stress and the pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Antioxidants, oxidative stress, and degenerative neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

The pathogenesis of cell death in Parkinson's disease--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Neuroinflammation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Interleukin-1 mediates Alzheimer and Lewy body pathologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Synuclein activates microglia in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Alpha-synuclein activates stress signaling protein kinases in THP-1 cells and microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Alpha-synuclein expression modulates microglial activation phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Activation of microglia induces symptoms of Parkinson's disease in wild-type, but not in IL-1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Non-motor symptoms in patients with Parkinson's disease - correlations with inflammatory cytokines in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Innate and adaptive immunity for the pathobiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Microglial phenotype: is the commitment reversible?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Increase in peripheral CD4 bright+ CD8 dull+ T cells in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Alterations of T-lymphocyte populations in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

What genetics tells us about the causes and mechanisms of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Genetic correction of a LRRK2 mutation in human iPSCs links parkinsonian neurodegeneration to ERK-dependent changes in gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Mutations in NR4A2 associated with familial Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Genome-wide association study confirms extant PD risk loci among the Dutch

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Human leukocyte antigen variation and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Association of the human leucocyte antigen region with susceptibility to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Inflammation and adaptive immunity in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Anti-inflammatory properties rather than anti-oxidant capability is the major mechanism of neuroprotection by sodium salicylate in a chronic rotenone model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

NSAID use and the risk of Parkinson's disease: systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

NSAID use and risk of Parkinson disease: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2014.982795

10.3109/00207454.2014.982795

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference